Biotechnology-derived cardiovascular therapeutics and toxicity

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalCardiovascular Toxicology
Volume3
Issue number1
DOIs
StatePublished - Sep 5 2003
Externally publishedYes

Fingerprint

Biotechnology
Toxicity
Cardiovascular Diseases
Heart Failure
Cytokines
Therapeutics

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Toxicology

Cite this

Biotechnology-derived cardiovascular therapeutics and toxicity. / Kang, Yujian.

In: Cardiovascular Toxicology, Vol. 3, No. 1, 05.09.2003, p. 1-3.

Research output: Contribution to journalEditorial

@article{efdd44b9d29548c79ea8dd1528dd22f9,
title = "Biotechnology-derived cardiovascular therapeutics and toxicity",
author = "Yujian Kang",
year = "2003",
month = "9",
day = "5",
doi = "10.1385/CT:3:1:1",
language = "English (US)",
volume = "3",
pages = "1--3",
journal = "Cardiovascular Toxicology",
issn = "1530-7905",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Biotechnology-derived cardiovascular therapeutics and toxicity

AU - Kang, Yujian

PY - 2003/9/5

Y1 - 2003/9/5

UR - http://www.scopus.com/inward/record.url?scp=0041929634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041929634&partnerID=8YFLogxK

U2 - 10.1385/CT:3:1:1

DO - 10.1385/CT:3:1:1

M3 - Editorial

VL - 3

SP - 1

EP - 3

JO - Cardiovascular Toxicology

JF - Cardiovascular Toxicology

SN - 1530-7905

IS - 1

ER -